Navigation Links
Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies
Date:7/7/2009

LONDON, July 7 /PRNewswire/ -- Frost & Sullivan has conferred two prestigious awards on Veolia Water Solutions & Technologies (VWS). The "2008 Frost & Sullivan European Pharmaceutical Water & Wastewater Treatment Business Development Strategy Leadership Award," lauds VWS for its successful strategies that have enabled it to consolidate its position as one of the leading process water and wastewater solution providers for the pharmaceutical industry in Europe. The "2008 Frost & Sullivan CEO of the Year Award in the Global Water and Wastewater Treatment Technology Market" is presented to Jean Michel Herrewyn for his stellar role in steering this growth.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"The success of VWS in the highly process critical pharmaceutical industry is attributed to its well structured business strategies that center on customised advanced treatment technologies and comprehensive, fully integrated treatment and service solutions," notes Frost & Sullivan Research Analyst Karthikeyan Ravikumar. "Superior product quality, coupled with effective after sales services, has resulted in high levels of customer satisfaction."

Since 2005, VWS has also been successful in offering turnkey solutions on a global basis to the pharmaceutical industry. High quality standard equipment offerings include ORION(TM), QUATTRO(TM), TRITON and POLARIS for producing Purified Water (PW) and Water for Injection (WFI). The company also offers two unique after sales services - AQUATREND(TM) and AQUAMOVE(TM). These have been focused on achieving high levels of customer service satisfaction.

With Jean Michel at the helm, the company has successfully shifted from a market segment-based approach (which involved the division of the water industry into three segments: municipal, industrial water and industrial wastewater treatment) to one focused on water and wastewater treatment technologies.

"Realising that the key expertise of VWS was in technologies, Jean Michel emphasised the company's strategic focus on water and wastewater treatment technologies, placing technology at the core of the company's water and wastewater treatment value offering to customers," explains Frost & Sullivan Research Analyst Fredrick Harry Royan. "This focus has become central to the business strategy of VWS."

Another initiative undertaken during the tenure of Jean Michel has been the development of centres of excellence, especially among subsidiaries. This enterprise has already materialised with dedicated Centres of Excellence for key industrial sectors such as food and beverage and pharmaceuticals. Currently, VWS is the only company in the market with a team - The Veolia Pharmaceutical Competence Centre - dedicated to the pharmaceutical industry.

Lately, the company has adopted a more discerning approach to treatment technologies. It is currently equipped with a strong portfolio of thermal desalination solutions.

"This complements the Reverse Osmosis (RO) membrane capabilities built up within VWS&T, resulting in aggressive growth in the desalination plant market in the Middle East," states Royan. "This was recently highlighted when the company secured the contract of building one of the worlds largest thermal desalination plant with a capacity of 800,000 m3/day for the Jubail Industrial City in Saudi Arabia."

In the last few years, the company has adopted an aggressive growth strategy based on major acquisitions. The defining factor of the acquisition strategy has been a focus on sustainability, which is reflected in the technologies and solutions acquired in the last few years.

The Frost & Sullivan Award for Business Development Strategy Leadership is presented each year to the company that has demonstrated excellence in business development within the industry. The Award recognises the company's ability to best perceive consumer needs, develop products and/or services that meet consumer needs, successfully introduce products or services to the industry, and identify new market segments to expand the existing customer base. Through a combination of vision, technology, and successful marketing, the Award recipient has demonstrated superior market growth skills.

The Frost & Sullivan CEO of the Year Award is bestowed each year upon the CEO or executive who has demonstrated leadership excellence within his or her industry. Gains in market share and decisions that improve earnings and grow the company, as well as leadership that affect observable changes in the industry, are common CEO performance measurement criteria and are important metrics Frost & Sullivan utilises in its CEO of the Year Award selection process. A CEO's vision, risk-taking, and leadership also can have a profound effect on performance. Frost & Sullivan seeks to identify a highly successful CEO whose leadership, vision, and successful risk-taking stand out among his or her peers. The Award recipient also has distinguished himself or herself from competitors by pursuing a unique restructuring, organisational management reengineering, or competitive roadmap that has resulted in propelling or sustaining the company's market position.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Veolia Water Solutions & Technologies

Veolia Water Solutions & Technologies (VWS), subsidiary of Veolia Water, is a leading design & build company and a specialized provider of technological solutions in water treatment. With over 8,900 employees in 57 countries, Veolia Water Solutions & Technologies recorded revenue of euro 2.5 billion in 2008.

Veolia Water, the water division of Veolia Environnement, is the world leader in water and wastewater services. Specialized in outsourcing services for municipal authorities, as well as industrial and service companies, Veolia Water serves 139 million people worldwide. With 93,400 employees, its 2008 revenues amounted to euro 12.6 billion.

www.veoliawaterst.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Contact:

Ciara Jamie Connolly, Senior Events & Promotions Executive EMEA, Best Practices, Frost & Sullivan, ciara.connolly@frost.com, P: 0044 (0) 207.915.7868, F: 0044 (0) 207.730.3343, www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. APAC Sensors Market Likely to be Driven by Medical and Process Industries in 2009, Says Frost & Sullivan
2. Multiple Advantages to Boost Deployment of Wireless and Handheld Devices in Healthcare, States Frost & Sullivan
3. Frost & Sullivan European Gastroenterology Technology Implementation of the Year Award Bestowed on Crospon
4. Cellular Technology Extends the Boundaries of E-healthcare, Says Frost & Sullivan
5. Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
6. Hospital Information Systems (HIS) Markets in Europe: Frost & Sullivan Reveals the Cost, Crunch and the Care Value
7. Pulse Oximetry Entrenched as Standard-of-Care in Patient Monitoring, States Frost & Sullivan
8. Frost & Sullivan: Self-Monitoring and POC Diabetes Tests Reveal Potential for Significant Growth, Boosting the European Diabetes Diagnostics Market
9. Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award
10. Frost & Sullivan Sees Opportunities in Chinese Vaccine Industry
11. Digital Mammography and Clinical Review Display Units Energising the European Markets for Medical Imaging Display Monitors, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... ... May kicked off with Melanoma Monday , a multi-agency effort to raise ... encouraging her patients, as well as residents all around Dallas, Cleburne, Irving, and Plano, ... in the future. , The dermatology-specific awareness month ends with “Don’t Fry Day,” established ...
(Date:5/4/2016)... ... May 04, 2016 , ... Momsense, Inc. ... The company’s patented technology, The Smart Breastfeeding Meter, is designed to monitor and ... technology is now available for purchase at Target.com . , Breastfeeding ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of ... life forever with a same-day LASIK procedure at Christenbury Eye Center. The ... Jonathan Christenbury performed her surgery the same day as her in-office consultation and eye ...
(Date:5/4/2016)... ... May 04, 2016 , ... The preeminent surgical aftercare facility Pearl Recovery ... breast cancer surgery. In March 2016, the 61-year-old model and reality TV star was ... occurs in the milk ducts, according to an interview with the Daily Mail ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the ... In upcoming months, AudioEducator has lined up some informative training session for the ... give complete compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
(Date:5/3/2016)... 4, 2016 Research and Markets ... Stem Cell Therapy Market Outlook 2020" report to ... ) , ,Recombinant technology has improved significantly in past ... be developed in coming years. Many cancer drugs have ... cell therapies are also expected to be developed with ...
(Date:5/3/2016)... , May 3, 2016  While you may be familiar with watching a film or ... also known as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized ... innovative technology. Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
Breaking Medicine Technology: